Advent Life Sciences LLP - 13 Feb 2026 SCHEDULE 13G/A Report for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA)

Filing Manager
Advent Life Sciences LLP
Reporting Manager
Rajesh Parekh, Ph.D.
Security
Aura Biosciences, Inc. Common Stock, par value $0.00001 per share
Symbol
AURA
Shares outstanding
62,124,648 shares
Disclosed Ownership
2,071,857 shares
Ownership
3.3%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 20:48:03 UTC
Date of event
13 Feb 2026
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Advent Life Sciences LLP 3.3% 2,023,857 0 2,023,857 /s/Rajesh Parekh, Ph.D. General Partner of Advent Life Sciences LLP
Advent Life Sciences Fund I LP 3.3% 2,023,857 0 2,023,857 /s/Rajesh Parekh, Ph.D. General Partner of Advent Life Sciences LLP acting in its capacity as Manager of Advent Life Sciences Fund I LP
Rajesh Parekh, Ph.D. 3.3% 2,071,857 0 2,023,857 /s/Rajesh Parekh, Ph.D. /s/Rajesh Parekh, Ph.D.
Advent Life Sciences Fund III LP 3.3% 2,023,857 0 2,023,857 /s/Rajesh Parekh, Ph.D. General Partner of Advent Life Sciences LLP acting in its capacity as Manager of Advent Life Sciences Fund III LP
ALS III Carry and Co-Invest LP 3.3% 2,023,857 0 2,023,857 /s/Rajesh Parekh, Ph.D. General Partner of Advent Life Sciences LLP acting in its capacity as Manager of ALS III Carry and Co-Invest LP
Advent-Harrington Impact Fund LP 3.3% 2,023,857 0 2,023,857 /s/Rajesh Parekh, Ph.D. General Partner of Advent Life Sciences LLP acting in its capacity as Manager of Advent-Harrington Impact Fund LP